Primorigen Biosciences LLC, a Madison biotech start-up company, has raised $2.45 million in a first round of financing.
Primorigen’s president is Chuck Oehler, who also held executive positions at Promega and other biotech firms, and was president and consulting executive director of the Wisconsin Biotechnology Association during a period of rapid growth.
His firm, the Oehler Group, has helped start-ups and other companies raise about $30 million, according to his biography on the Web site for the University of Wisconsin-Madison business school, where he serves on the entrepreneurship program’s advisory board.